Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Stimulator of interferon genes

Tag: stimulator of interferon genes

Merck KGaA and Mersana Therapeutics Sign Research Collaboration and Commercial License...

ADC Review | Editorial Team
German based Merck KGaA, and Mersana Therapeutics USA have signed a research collaboration and commercial license agreement to discover novel antibody-drug conjugates (ADCs) leveraging...
HPAPI Lab at Abzena. Photo Courtesy: 2019 Abzena.

Addressing the Challenges of Bioconjugate Medicines

Mark Frigerio, Ph.D.
Abstract The continuing advancements in bioconjugate medicines from delivery of potent cytotoxins to vaccine-, oligonucleotide-, radionuclide-, immunomodulator- and check-point inhibitor-conjugates, can start to address the...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X